Muller, Yunhua L. http://orcid.org/0000-0001-5007-2107
Saporito, Michael
Day, Samantha
Bandesh, Khushdeep http://orcid.org/0000-0002-5057-7313
Koroglu, Cigdem
Kobes, Sayuko
Knowler, William C.
Hanson, Robert L. http://orcid.org/0000-0002-4252-7068
Van Hout, Cristopher V.
Shuldiner, Alan R.
Bogardus, Clifton
Baier, Leslie J.
,
Funding for this research was provided by:
Intramural Research Programme of National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Regeneron Pharmaceuticals
Article History
Received: 5 November 2021
Revised: 18 April 2022
Accepted: 26 May 2022
First Online: 10 June 2022
Competing interests
: The authors declare that there is no conflict of interest. ARS or CVVH is or was full-time employees of the Regeneron Genetics Center from Regeneron Pharmaceuticals Inc. and receive or received stock options and restricted stock units as compensation.
: These participants had provided written consent for DNA sequencing; and informed consent was obtained from all subjects. The consent was approved by the Institutional Review Board of the NIDDK and/or by the Phoenix Area Indian Health Service Institutional Review Board.